Home » Topics » BioWorld Science

BioWorld Science
RSS

Methyltransferase-like protein 11A inhibitors identified at Purdue Research Foundation

Dec. 5, 2019

Bristol-Myers Squibb synthesizes new RORC inverse agonists

Dec. 5, 2019

E-Scape Bio describes new LRRK2 inhibitors

Dec. 5, 2019

First-in-human data for NTM-1634 botulinum vaccine

Dec. 5, 2019

Phase I data presented for the oncolytic virus DNX-2401 as treatment of DIPG

Dec. 5, 2019

Interim data presented from first-in-human study of AMG-596

Dec. 5, 2019

Kancera presents data from in-depth analysis of KAN-D567 phase Ib program

Dec. 5, 2019

First patient dosed in phase II study of zilucoplan for the treatment of IMNM

Dec. 5, 2019

FDA clears IND application for ICTCAR-014

Dec. 5, 2019

Cerevance initiates phase II study of CVN-424 in Parkinson's disease

Dec. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...